Medical Oddities: Could GLP-1s Curb Violence?
Five studies, one question: are we overlooking hidden drivers of health?
-
By
-
Teraya Smith
-
June 25, 2026
-
Objective:
To explore whether GLP-1 receptor agonists can influence behavioral pathways linked to violence.
Approach:
- Study Design: Cross-sectional analysis using data from a nationally representative 2025 survey, comparing 821 adults who had used GLP-1 medications.
- Participant Comparison: 597 current users of GLP-1 medications were compared with 224 former users.
Key Findings:
- Impulsivity and alcohol use were strongly associated with self-reported violent behavior.
- The association between impulsivity and violent behavior was attenuated by about 62% among current GLP-1 users.
- Alcohol-related findings were less consistent but pointed in a similar direction.
- GLP-1 use was not independently associated with lower violence rates.
Interpretation:
GLP-1 medications may influence how risk factors translate into violent behavior.
Limitations:
- The study's cross-sectional design cannot establish causality.
Conclusion:
The findings suggest an unexpected link between GLP-1 medications and behavioral pathways related to violence.
